| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,680 | 4,120 | 10:13 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.08. | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 05.08. | Earnings Call: Umsatz von Acacia Research springt im 2. Quartal 2026 durch Lizenzerfolg in die Höhe | 1 | Investing.com Deutsch | ||
| ACACIA RESEARCH Aktie jetzt für 0€ handeln | |||||
| 05.08. | ACACIA RESEARCH CORP - 8-K, Current Report | - | SEC Filings | ||
| 25.06. | ACACIA RESEARCH CORP - 8-K, Current Report | 3 | SEC Filings | ||
| 07.05. | Acacia Research Q1 2026 slides show mixed results, strong liquidity | 5 | Investing.com | ||
| 07.05. | ACACIA RESEARCH CORP - 8-K, Current Report | - | SEC Filings | ||
| 06.05. | Acacia Research Q1 2026 Earnings Preview | 2 | Seeking Alpha | ||
| 12.03. | ACACIA RESEARCH CORP - 10-K, Annual Report | 3 | SEC Filings | ||
| 11.03. | Acacia Research signals $2M annualized cost savings from Deflecto plant consolidation while maintaining $340M cash and securities | 2 | Seeking Alpha | ||
| 11.03. | ACACIA RESEARCH CORP - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Acacia Research Q4 2025 Earnings Preview | 1 | Seeking Alpha |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 19,960 | +0,81 % | BERENBERG stuft Formycon auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für das Biosimilar-Unternehmen Formycon nach Zahlen mit einem Kursziel von 30 Euro auf "Buy" belassen. Analyst Christian Ehmann... ► Artikel lesen | |
| GAUZY | 0,390 | -0,31 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Delayed Filing of Annual Report on Form 20-F | TEL AVIV, Israel, May 26, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that on May 19, 2026... ► Artikel lesen | |
| VEECO INSTRUMENTS | 39,980 | +4,55 % | Veeco Instruments Inc.: Veeco Reports Second Quarter 2026 Financial Results | Second Quarter 2026 Highlights: Revenue of $193.5 million, compared with $166.1 million in the same period last yearGAAP net income of $11.9 million, or $0.18 per diluted share, compared with $11.7... ► Artikel lesen | |
| NANOVIRICIDES | 1,050 | -1,87 % | NanoViricides: The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon | SHELTON, CT / ACCESS Newswire / August 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that... ► Artikel lesen | |
| KOPIN | 3,847 | -0,62 % | Fabric.AI (Nasdaq: FABC) Stockholders Ratify Kopin Strategic Partnership to Develop Neural I/o MicroLED Optical Interconnect Technology for Next Generation AI Data Centers | NEW YORK, NY, June 24, 2026 (GLOBE NEWSWIRE) -- Fabric.AI, Inc. (Nasdaq: FABC) ("Fabric.AI" or the "Company"), a fabless semiconductor company developing MicroLED-based optical interconnects for AI... ► Artikel lesen | |
| ZENTEK | 0,372 | 0,00 % | Zentek Ltd: Zentek to transfer shares from Nasdaq to OTC | ||
| ONTO INNOVATION | 232,40 | -0,56 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| GOMSPACE | 1,025 | +0,20 % | GomSpace Group AB: Q2 Financial Reporting Confirms a Strong First Half of 2026: 30% Growth, Positive EBIT, Reinforced Balance Sheet and Guidance Maintained | GomSpace posts above-market 30% revenue growth, improved profitability with 11% EBITDA and positive EBIT, and a strengthened balance sheet with equity ratio increase to 41%, while progressing its shift... ► Artikel lesen | |
| SOLESENCE | 0,950 | 0,00 % | Solésence, Inc.: Solésence Reports Second Quarter 2026 Financial Results | Quarterly Report Filed on Form 10-Q Company to Host Conference Call at 5:00 p.m. ET Today ROMEOVILLE, Ill., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically... ► Artikel lesen | |
| NVE | 87,50 | 0,00 % | Dividendenbekanntmachungen (03.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR BF SPA IT0005187460 - 0,038 EUR CITIZENS & NORTHERN CORPORATION US1729221069 0... ► Artikel lesen | |
| SMOLTEK NANOTECH | 0,109 | -1,36 % | SMOLTEK NANOTECH HOLDING AB: Smoltek presents Q2 report at Redeye | ||
| DOTZ NANO | 0,013 | -6,02 % | DOTZ NANO LIMITED: Cleansing Notice | ||
| ADVANCE ZINCTEK | 0,366 | 0,00 % | ADVANCE ZINCTEK LIMITED: Corporate Governance Statement | ||
| LAMPETIA | 0,161 | -13,44 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| RIBER | 8,780 | 0,00 % | RIBER: FIRST-HALF 2026 BUSINESS ACTIVITY Business growth, resilient order book and continued rollout of ROSIE | FIRST-HALF 2026 BUSINESS ACTIVITYBusiness growth, resilient order book and continued rollout of ROSIE Bezons, July 22, 2026 - 8:00 am - RIBER, the global leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen |